Medical Nutrition Equity Act of 2017

Legislation to require coverage of medically necessary foods for disease and disorders of the gastrointestinal system in pediatric patients. Coverage mandate would apply to Medicaid, Medicare, Children's Health Insurance Program, TRICARE, and private payers (HR 2587 / S. 1194)

Client expense: Not reported · Firm income: $21,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare Part D Affirming the importance of the Orphan Drug Act, applauding its lifesaving contributions over its 35-year history, and recognizing the need to continue supporting research and development for rare diseases; H.Res.1154 A resolution affirming the importance of the Orphan Drug Act, applauding the life-saving accomplishments of the Act during its 35-year history, and recognizing the need to continue support for research and development of new therapies for rare diseases; S.Res.690 Step therapy in Medicare Advantage plans Restoring the Patient's Voice Act of 2017; H.R.2077 Rare disease Advancement, Research, and Education Act of 2018; H.R.5115 National Institutes of Health funding Food and Drug Administration appropriations Orphan Drug Act Medical Nutrition Equity Act of 2017; H.R.2587, S.1194 Short-term, limited-duration health plans Association health plans Section 1115 waivers Section 1332 waivers Copay accumulator programs FY19 Labor, Health and Human Services, Education/Defense appropriations conference report; H.R.6157 Medicaid expansion Pediatric subspecialty loan repayment reauthorization Patient-focused drug development Human gene therapy for rare diseases Rare disease early development and the role of pre-investigational new drug application meetings International pricing index model for Medicare part B drugs Newborn Screening Saves Lives Act reauthorization Neurological Conditions Surveillance System funding MODERN Labeling Act of 2018; S.3519 ENROLL Act of 2018; H.R.7102

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

S. 1194, Medical Nutrition Equity Act; H.R. 4724

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 1194, Medical Nutrition Equity Act; H.R. 4724, Medicare IVIG Access Enhancement Act

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 1194, Medical Nutrition Equity Act; H.R. 4724, Medicare IVIG Access Enhancement Act

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 1194, Medical Nutrition Equity Act; H.R. 4274, Medicare IVIG Access Enhancement Act

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 1194, Medical Nutrition Equity Act; H.R. 4724, Medicare IVIG Access Enhancement Act

Client expense: Not reported · Firm income: Not reported

S. 1194, Medical Nutrition Equity Act; H.R. 4724, Medicare IVIG Access Enhancement Act

Client expense: Not reported · Firm income: Not reported

HR 2587/S1194: Medical Nutrition Equity Act of 2017 HR6: Support for Patients and Communities Act 340B Drug Discount Program Orphan Drug Act Gene Therapy Drug Pricing

Client expense: $230,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to pharmaceutical prices. H.R. 6, SUPPORT for Patients and Communities Act; S.2680, Opioid Crisis Response Act of of 2018 and issues related to controlled substances; monitored S. 2554 / H.R. 6143, the Patient Right to Know Drug Prices Act; monitored H.R. 3325, the Advancing Care for Exceptional Kids Act (ACE Kids) and H.R. 7212, IMPROVE Act. S. 1194, Medical Nutrition Equity Act. H.R. 4724, Medicare IVIG Access Enhancement Act.

Client expense: Not reported · Firm income: $52,500

Government targets: HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, SENATE

Co-sponsorship of the Medical Nutrition Equity Act (S. 1194/H.R. 2587)

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Co-sponsorship of the Medical Nutrition Equity Act (S. 1194/H.R. 2587)

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislation to require coverage of medically necessary foods for disease and disorders of the gastrointestinal system in pediatric patients. Coverage mandate would apply to Medicaid, Medicare, Children's Health Insurance Program, TRICARE, and private payers (HR 2587 / S. 1194)

Client expense: Not reported · Firm income: $19,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislation to require coverage of medically necessary foods for disease and disorders of the gastrointestinal system in pediatric patients. Coverage mandate would apply to Medicaid, Medicare, Children's Health Insurance Program, TRICARE, and private payers (HR 2587 / S. 1194)

Client expense: Not reported · Firm income: $12,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2: Agriculture Improvement Act of 2018; provisions related to Association Health Plans H.R. 2587: Medical Nutrition Equity Act of 2017; all provisions H.R. 3325: Advancing Care for Exceptional (ACE) Kids Act; All provisions H.R. 6261: Improving Choices in Health Care Coverage Act; All provisions S. 428: ACE Kids Act of 2017; all provisions S. 1194: Medical Nutrition Equity Act of 2017; all provisions S. 2507: Improving Choices in Health Care Coverage Act; all provisions S. 3042: Agriculture Improvement Act of 2018; provisions related to Association Health Plans S. 3388: Ensuring Coverage for Patients with Pre-Existing Conditions Act; all provisions H.J. Res. 140 - Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Department of the Treasury, the Department of Labor, and the Department of Health and Human Services relating to "Short-Term, Limited-Duration Insurance; all provisions S.J. Res. 63 - A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury, Secretary of Labor, and Secretary of Health and Human Services relating to "Short-Term, Limited Duration Insurance"; all provisions Draft Bill: To amend the HITECH Act to allow an individual to obtain a copy of such individuals protected health information at no cost in certain circumstances, and for other purposes; all provisions of draft Centers for Medicare & Medicaid Services Regulation# CMS-1693-P: Medicare Program: Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY 2019; Medicare Shared Savings Program Requirements; Quality Payment Program, and Medicaid Promoting Interoperability Program.; all provisions Centers for Medicare & Medicaid Services Regulation# CMS-9920-F: Adoption of Methodology for HHS-operated Permanent Risk Adjustment Program under the Patient Protection and Affordable Care Act for the 2017 Benefit Year; all provisions Centers for Medicare & Medicaid Services Regulation# CMS-9924-F: Short-term, Limited-Duration Insurance; all provisions Centers for Medicare & Medicaid Services Health Plan Management System Memo Re: Prohibition on Imposing Mandatory Step Therapy for Access to Part B Drugs and Services; all provisions Centers for Medicare & Medicaid Services - Section 1332: State Innovation Waivers; Provisions regarding Michigans Waiver Application Centers for Medicare & Medicaid Services - Section 1332: State Innovation Waivers; Provisions regarding New Hampshires Waiver Application Centers for Medicare & Medicaid Services - Section 1115: State Innovation Waivers; Provisions regarding Kentuckys Health Waiver Application work requirements to Medicaid

H.R. 2: Agriculture Improvement Act of 2018; provisions related to Association Health Plans H.R. 2587: Medical Nutrition Equity Act of 2017; all provisions H.R. 3325: Advancing Care for Exceptional (ACE) Kids Act; All provisions H.R. 6261: Improving Choices in Health Care Coverage Act; All provisions S. 428: ACE Kids Act of 2017; all provisions S. 1194: Medical Nutrition Equity Act of 2017; all provisions S. 2507: Improving Choices in Health Care Coverage Act; all provisions S. 3042: Agriculture Improvement Act of 2018; provisions related to Association Health Plans S. 3388: Ensuring Coverage for Patients with Pre-Existing Conditions Act; all provisions H.J. Res. 140 - Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Department of the Treasury, the Department of Labor, and the Department of Health and Human Services relating to "Short-Term, Limited-Duration Insurance; all provisions S.J. Res. 63 - A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury, Secretary of Labor, and Secretary of Health and Human Services relating to "Short-Term, Limited Duration Insurance"; all provisions Draft Bill: To amend the HITECH Act to allow an individual to obtain a copy of such individuals protected health information at no cost in certain circumstances, and for other purposes; all provisions of draft Centers for Medicare & Medicaid Services Regulation# CMS-1693-P: Medicare Program: Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY 2019; Medicare Shared Savings Program Requirements; Quality Payment Program, and Medicaid Promoting Interoperability Program.; all provisions Centers for Medicare & Medicaid Services Regulation# CMS-9920-F: Adoption of Methodology for HHS-operated Permanent Risk Adjustment Program under the Patient Protection and Affordable Care Act for the 2017 Benefit Year; all provisions Centers for Medicare & Medicaid Services Regulation# CMS-9924-F: Short-term, Limited-Duration Insurance; all provisions Centers for Medicare & Medicaid Service - Section 1332: State Innovation Waivers; Provisions regarding Michigans Waiver Application Centers for Medicare & Medicaid Service - Section 1332: State Innovation Waivers; Provisions regarding New Hampshires Waiver Application Centers for Medicare & Medicaid Services - Section 1115: State Innovation Waivers; Provisions regarding Kentuckys Health Waiver Application work requirements to Medicaid

H.R. 2587: Medical Nutrition Equity Act of 2017; all provisions H.R. 3325: Advancing Care for Exceptional (ACE) Kids Act; All provisions S. 428: ACE Kids Act of 2017; all provisions S. 1194: Medical Nutrition Equity Act of 2017; all provisions S. 3388: Ensuring Coverage for Patients with Pre-Existing Conditions Act; all provisions Centers for Medicare & Medicaid Services Regulation# CMS-1693-P: Medicare Program: Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY 2019; Medicare Shared Savings Program Requirements; Quality Payment Program, and Medicaid Promoting Interoperability Program.; all provisions Centers for Medicare & Medicaid Services - Section 1332: State Innovation Waivers; Provisions regarding Michigans Waiver Application Centers for Medicare & Medicaid Service - Section 1115: State Innovation Waivers; Provisions regarding Kentuckys Waiver Application work requirements to Medicaid Centers for Medicare & Medicaid Service - Section 1332: State Innovation Waivers; Provisions regarding New Jerseys Waiver Application-Reinsurance Centers for Medicare & Medicaid Service - Section 1115: State Innovation Waivers; Provisions regarding Utahs Waiver Application work requirements to Medicaid

Client expense: $130,000 · Firm income: Not reported

Issues related to pharmaceutical prices. H.R. 6, SUPPORT for Patients and Communities Act; S.2680, Opioid Crisis Response Act of of 2018 and issues related to controlled substances; monitored S. 2554 / H.R. 6143, the Patient Right to Know Drug Prices Act; monitored H.R. 3325, the Advancing Care for Exceptional Kids Act (ACE Kids). S. 1194, Medical Nutrition Equity Act. H.R. 4724, Medicare IVIG Access Enhancement Act.

Client expense: Not reported · Firm income: $52,500

Government targets: HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, SENATE

HR 2587/S1194: Medical Nutrition Equity Act of 2017 HR6: Support for Patients and Communities Act 340B Drug Discount Program Orphan Drug Act Gene Therapy Drug Pricing

Client expense: $250,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare Part D Step therapy in Medicare Advantage plans Restoring the Patient's Voice Act of 2017; H.R.2077 Rare disease Advancement, Research, and Education Act of 2018; H.R.5115 National Institutes of Health funding Food and Drug Administration appropriations Orphan Drug Act Senator Cassidy's "Ideas to Make Health Care Affordable Again" white paper Medical Nutrition Equity Act; H.R.2587, S.1194 Short-term, limited-duration health plans Association health plans Medicaid waivers Section 1332 waivers Copay accumulator programs Patient-focused drug development Biological products marketplace Slowly progressive low-prevalence rare diseases HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs FY19 Labor, Health and Human Services, Education/Defense appropriations conference report; H.R.6157 Ensuring Coverage for Patients with Pre-Existing Conditions Act; S.3388 Medicaid expansion Pediatric subspecialty loan repayment reauthorization Medical expense deduction Humanitarian Device Exemption (HDE) program Risk adjustment payments

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

Co-sponsorship of the Medical Nutrition Equity Act (S. 1194/H.R. 2587)

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Co-sponsorship of the Medical Nutrition Equity Act (S. 1194/H.R. 2587)

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislation to require coverage of medically necessary foods for disease and disorders of the gastrointestinal system in pediatric patients. Coverage mandate would apply to Medicaid, Medicare, Children's Health Insurance Program, TRICARE, and private payers (HR 2587 / S. 1194)

Client expense: Not reported · Firm income: $15,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 2587/S1194: Medical Nutrition Equity Act of 2017 HR6: Support for Patients and Communities Act 340B Drug Discount Program Orphan Drug Act Gene Therapy Drug Pricing

Client expense: $540,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare Part D Right to Try Act; S.204 Rare disease Advancement, Research, and Education Act of 2018; H.R.5115 National Institutes of Health funding Food and Drug Administration Appropriations Orphan Drug Act Medical Nutrition Equity Act; H.R.2587, S.1194 Congressionally Directed Medical Research Program Short-term, limited-duration health plans Association health plans Accelerated Approval Medicaid waivers Inpatient prospective payment system (IPPS) proposed rule Patient Advocacy Transparency Act; S.3000 HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

HR 2587/S1194: Medical Nutrition Equity Act of 2017 HR6: Support for Patients and Communities Act 340B Drug Discount Program Orphan Drug Act Gene Therapy Drug Pricing

Client expense: $540,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.247, Health Savings Account Expansion Act of 2017 H.R.277, American Health Care Reform Act of 2017 H.R.1313, Preserving Employee Wellness Programs Act H.R.1628, American Health Care Act of 2017 H.R.1953, Treat and Reduce Obesity Act of 2017 H.R.2430, FDA Reauthorization Act of 2017 H.R.2587, Medical Nutrition Equity Act of 2017 H.R.3124, Preventing Diabetes in Medicare Act of 2017 H.R.4454, Chronic Wasting Disease Management Act H.R.4978, Chronic Disease Management Act of 2018 S.28, Health Savings Account Expansion Act of 2017 S.830, Treat and Reduce Obesity Act of 2017 S.870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 S.934, FDA Reauthorization Act of 2017 S.1194, Medical Nutrition Equity Act of 2017 S.1299, Preventing Diabetes in Medicare Act of 2017 S.2410, Chronic Disease Management Act of 2018

Client expense: $150,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislation to require coverage of medically necessary foods for disease and disorders of the gastrointestinal system in pediatric patients. Coverage mandate would apply to Medicaid, Medicare, Children's Health Insurance Program, TRICARE, and private payers (HR 2587 / S. 1194)

Client expense: Not reported · Firm income: $19,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medical Nutrition Equity Act (S. 1194/H.R. 2587)

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medical Nutrition Equity Act (S. 1194/H.R. 2587)

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Bipartisan Health Care Stabilization Act Medicare Part D Right to Try Act; H.R.5247, S.204 Rare disease Advancement, Research, and Education Act of 2018; H.R.5115 National Institutes of Health Funding Food and Drug Administration Funding Orphan Drug Act Medical Nutrition Equity Act; H.R.2587, S.1194 Advancing Care for Exceptional Kids Act; S.428 Pediatric Device Consortia Grant Program Congressionally Directed Medical Research Program Rare Disease Day Resolution; S.Res.423 Short-term, limited-duration health plans Association health plans OPEN Act; H.R.1223, S.1509 Advancing Access to Precision Medicine Act of 2018; H.R.5062 Restoring the Patient's Voice Act of 2017; H.R.2077

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

H.R.247, Health Savings Account Expansion Act of 2017 H.R.277, American Health Care Reform Act of 2017 H.R.1313, Preserving Employee Wellness Programs Act H.R.1628, American Health Care Act of 2017 H.R.1953, Treat and Reduce Obesity Act of 2017 H.R.2430, FDA Reauthorization Act of 2017 H.R.2587, Medical Nutrition Equity Act of 2017 H.R.3124, Preventing Diabetes in Medicare Act of 2017 H.R.4454, Chronic Wasting Disease Management Act H.R.4978, Chronic Disease Management Act of 2018 S.28, Health Savings Account Expansion Act of 2017 S.830, Treat and Reduce Obesity Act of 2017 S.870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 S.934, FDA Reauthorization Act of 2017 S.1194, Medical Nutrition Equity Act of 2017 S.1299, Preventing Diabetes in Medicare Act of 2017 S.2410, Chronic Disease Management Act of 2018

Client expense: $150,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medical Nutrition Equity Act (S. 1194/HR. 2587)

Client expense: Not reported · Firm income: Not reported

the Medical Nutrition Equity Act (S. 1194/H.R. 2587)

Client expense: Not reported · Firm income: Not reported

the Medical Nutrition Equity Act (S. 1194/H.R. 2587)

Client expense: Not reported · Firm income: Not reported

Healthcare reform. Healthcare Common Procedure Coding Systems for biosimilars. Medicare Part D. Medicare DOS policy. Graham-Cassidy amendment to H.R.1628. Better Care Reconciliation Act. Children's Health Insurance Program Reauthorization. Medical Nutrition Equity Act; H.R.2587, S.1194. FDA Reauthorization Act; H.R.2430. FDA Office of Patient Affairs. Orphan Drug Tax Credit. Right to Try Act; H.R.878, S.204. FDA Funding. NIH Funding. Zika Appropriations. Newborn Screening Appropriations.

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA), White House Office

Legislation to require coverage of medically necessary foods for disease and disorders of the gastrointestinal system in pediatric patients. Coverage mandate would apply to Medicaid, Medicare, Children's Health Insurance Program, TRICARE, and private payers (HR 2587 / S. 1194)

Client expense: Not reported · Firm income: $18,000

Government targets: Consumer Product Safety Commission (CPSC), HOUSE OF REPRESENTATIVES, SENATE

H.R.247, Health Savings Account Expansion Act of 2017 H.R.277, American Health Care Reform Act of 2017 H.R.1313, Preserving Employee Wellness Programs Act H.R.1628, American Health Care Act of 2017 H.R.1953, Treat and Reduce Obesity Act of 2017 H.R.2430, FDA Reauthorization Act of 2017 H.R.2587, Medical Nutrition Equity Act of 2017 H.R.3124, Preventing Diabetes in Medicare Act of 2017 H.R.4454, Chronic Wasting Disease Management Act H.R.4978, Chronic Disease Management Act of 2018 S.28, Health Savings Account Expansion Act of 2017 S.830, Treat and Reduce Obesity Act of 2017 S.870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 S.934, FDA Reauthorization Act of 2017 S.1194, Medical Nutrition Equity Act of 2017 S.1299, Preventing Diabetes in Medicare Act of 2017 S.2410, Chronic Disease Management Act of 2018

Client expense: $150,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislation to require coverage of medically necessary foods for disease and disorders of the gastrointestinal system in pediatric patients. Coverage mandate would apply to Medicaid, Medicare, Children's Health Insurance Program, TRICARE, and private payers (HR 2587 / S. 1194)

Client expense: Not reported · Firm income: $18,000

Government targets: Consumer Product Safety Commission (CPSC), HOUSE OF REPRESENTATIVES, SENATE

Legislation to require coverage of medically necessary foods for disease and disorders of the gastrointestinal system in pediatric patients. Coverage mandate would apply to Medicaid, Medicare, Children's Health Insurance Program, TRICARE, and private payers (HR 2587 / S. 1194)

Client expense: Not reported · Firm income: $18,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.247, Health Savings Account Expansion Act of 2017 H.R.277, American Health Care Reform Act of 2017 H.R.1313, Preserving Employee Wellness Programs Act H.R.1628, American Health Care Act of 2017 H.R.1953, Treat and Reduce Obesity Act of 2017 H.R.2430, FDA Reauthorization Act of 2017 H.R.2587, Medical Nutrition Equity Act of 2017 H.R.3124, Preventing Diabetes in Medicare Act of 2017 S.28, Health Savings Account Expansion Act of 2017 S.830, Treat and Reduce Obesity Act of 2017 S.870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 S.934, FDA Reauthorization Act of 2017 S.1194, Medical Nutrition Equity Act of 2017 S.1299, Preventing Diabetes in Medicare Act of 2017

Client expense: $150,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Healthcare reform Healthcare Common Procedure Coding Systems for biosimilars Medicare Part D Medicare DOS policy Graham-Cassidy amendment to H.R.1628 Better Care Reconciliation Act Children's Health Insurance Program Reauthorization Medical Nutrition Equity Act; H.R.2587, S.1194 FDA Reauthorization Act; H.R.2430 FDA Office of Patient Affairs Orphan Drug Tax Credit Right to Try Act; H.R.878, S.204 FDA Funding NIH Funding Zika Appropriations Newborn Screening Appropriations

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA), White House Office

Legislation to require coverage of medically necessary foods for disease and disorders of the gastrointestinal system in pediatric patients. Coverage mandate would apply to Medicaid, Medicare, Children's Health Insurance Program, TRICARE, and private payers (HR 2587 / S. 1194) Support funding and development of a safety registry for pediatric patients with inflammatory bowel disease (no specific legislation).

Client expense: Not reported · Firm income: $18,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.247, Health Savings Account Expansion Act of 2017 H.R.277, American Health Care Reform Act of 2017 H.R.1313, Preserving Employee Wellness Programs Act H.R.1628, American Health Care Act of 2017 H.R.1953, Treat and Reduce Obesity Act of 2017 H.R.2430, FDA Reauthorization Act of 2017 H.R.2587, Medical Nutrition Equity Act of 2017 H.R.3124, Preventing Diabetes in Medicare Act of 2017 S.28, Health Savings Account Expansion Act of 2017 S.830, Treat and Reduce Obesity Act of 2017 S.870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 S.934, FDA Reauthorization Act of 2017 S.1194, Medical Nutrition Equity Act of 2017 S.1299, Preventing Diabetes in Medicare Act of 2017

Client expense: $110,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

American Health Care Act; H.R.1628 Better Care Reconciliation Act Children's Health Insurance Program Reauthorization Medical Nutrition Equity Act; H.R.2587, S.1194 FDA Reauthorization Act; H.R.2430 FDA Office of Patient Affairs Enhanced Clinical Trial Design Act; S.1048 Orphan Drug Tax Credit Right to Try Act; H.R.878, S.204 OPEN Act; H.R.1223 FDA Funding NIH Funding RACE for Children Act; H.R.1231 Zika Appropriations Newborn Screening Appropriations

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA), White House Office